Focus
improper listing of patents
FTC Disputes Over 100 Asthma Inhaler Patents for Harming Consumer Choices
The patents could ‘significantly drive up the prices Americans must pay for medicines and drug products,’ the FTC chair said.
|
FTC Disputes Over 100 Asthma Inhaler Patents for Harming Consumer Choices
The patents could ‘significantly drive up the prices Americans must pay for medicines and drug products,’ the FTC chair said.
|